Key Points
The revised guidelines, issued on Sunday amid an uptick in coronavirus cases, stated that drugs such as Lopinavir-ritonavir, hydroxychloroquine, Ivermectin, Molnupiravir, Favipiravir, Azithromycin and Doxycycline should not be used for the treatment of adult COVID-19 patients in India...
The AIIMS/ICMR-COVID-19 National Task Force met on January 5 to revise the clinical guidance protocol..
It should be started within 10 days of onset of symptoms in those having moderate to severe disease with a high risk of progression (requiring supplemental oxygen) but who are not on IMV or ECMO...
You might be interested in
Antibiotics shouldn’t be used in Covid unless suspicion of bacterial infection: Centre’s guideline
07, Apr, 23Antibiotics should not be used in Covid cases unless there is clinical suspicion of bacterial infection, according to a revised guideline for the treatment of adult coronavirus patients issued by the Centre.
Govt releases fresh clinical guidance for COVID-19 amid rise in cases
19, Mar, 23In recent weeks, the risk of H3N2 influenza as well as COVID-19 has risen sharply. Several states have reported an uptick in cases, with officials issuing alerts and calling for precautionary measures to be taken.
Covid-19: Revised Covid guidelines advise against antibiotic use ‘unless there is clinical suspicion of bacterial infection’
20, Mar, 23As per the revised COVID-19 guidelines, "Antibiotics should not be used unless there is a clinical suspicion of bacterial infection. The possibility of coinfection of COVID-19 with other endemic infections must be considered. Systemic corticosteroids are not indicated in mild disease."
Health Ministry issues revised guidelines for Covid-19 amid rise in cases
19, Mar, 23Antibiotics should not be used unless there is clinical suspicion of bacterial infection. The possibility of coinfection of COVID-19 with other endemic infections must be considered. Systemic corticosteroids are not indicated in mild disease, revised guidelines said.
Amid rise in daily covid cases in India, ICMR to hold review meet today
20, Mar, 23The Ministry of Health and Family Welfare has issued revised guidelines for Covid-19 in the wake of the surge of cases
Risk of Guillain-Barre syndrome 6 times higher after Covid infection
27, Oct, 23A study conducted has identified a link between Covid-19 infection and an increased probability of receiving a diagnosis of Guillain-Barre syndrome (GBS) within a six-week timeframe.
Cough sound analysis assists in determining severity of Covid-19 patients
26, Sep, 23The study states that assessing the cough sounds can help in detecting the risk of severe pneumonia | Health
No antibiotics, plasma therapy to treat adult COVID patients: government
20, Mar, 23“Antibiotics should not be used unless there is clinical suspicion of bacterial infection.”
Covid-19 cases on the rise: Here's what you can do to avoid the virus
03, Apr, 23Though there is an increase in Covid cases, the need for hospitalisation is less as compared to previous waves.
WHO updates its guidance on treatments for COVID-19
03, Dec, 23WHO recommends the use of antiviral drug nirmatrelvir-ritonavir in patients with non-severe COVID-19 at high and moderate risk of hospital admission. The World Health Organization (WHO) has updated its guidance on treatments for patients with COVID-19, providing latest, trustworthy advice on the management of the disease to help doctors make better decisions.